This suggests that obesity impacts breast cancer progression by increasing the expression of key marker proteins of metastasis (i.e., MMP-9 and β-catenin) through FAK activation. This evidence concerns the gene MMP9 and obesity due to melanocortin 4 receptor deficiency.